Mechanism of Formation and Classification
The synthesis of biogenic amines occurs via decarboxylation—the removal of the $\alpha$-carboxyl group from a parent amino acid or its derivative. The reaction proceeds with the release of carbon dioxide ($CO_2$). Enzymes known as decarboxylases catalyze this process, requiring pyridoxal phosphate (PLP) as a coenzyme.
Based on their biological functions, biogenic amines are divided into three main groups:
- Neurotransmitters (ensure nerve impulse transmission) — serotonin, dopamine, GABA.
- Hormones (regulate systemic processes) — epinephrine (synthesized in the adrenal medulla).
- Local regulators (tissue hormones) — histamine.
Gamma-Aminobutyric Acid (GABA)
GABA is synthesized in neurons and serves as the principal inhibitory neurotransmitter in the central nervous system.
The precursor of GABA is glutamate (glutamic acid). Catalyzed by glutamate decarboxylase using PLP as a cofactor, $CO_2$ is cleaved from glutamate to yield GABA.
In clinical practice, GABA-derived medications are used for traumatic brain injuries, intellectual disability, cerebrovascular disorders, and endogenous depressions.
Acetylcholine Synthesis
Acetylcholine is also classified as a biogenic amine, and its formation in nervous tissue occurs in several steps:
- First, the amino acid serine undergoes decarboxylation (catalyzed by serine decarboxylase with the PLP cofactor) to form ethanolamine.
- Next, ethanolamine is methylated by ethanolaminemethyltransferase. The methyl group donor is SAM (S-adenosylmethionine), resulting in choline formation.
- In the final step, choline acetyltransferase combines choline and Acetyl-CoA to form acetylcholine.
Important: Impaired acetylcholine synthesis at neuromuscular junctions leads to a severe pathology known as myasthenia gravis (marked muscle weakness).
Serotonin Metabolism
Serotonin is a neurotransmitter of neural pathways, often referred to as the "pleasure hormone." It is synthesized in the hypothalamus, adrenal glands, and mast cells.
The starting substrate is the amino acid tryptophan. The process takes place in two steps:
- Hydroxylation of tryptophan using oxygen and tetrahydrobiopterin ($H_4 ext{BH}_4$) to form 5-hydroxytryptophan.
- Decarboxylation of the resulting product to yield serotonin.
Serotonin exerts diverse physiological effects: it regulates blood pressure, body temperature, and respiration, constricts blood vessels, stimulates smooth muscle contraction, and enhances gut motility. It is also released from mast cells, participating in allergic reactions.
Inactivation of Biogenic Amines
To prevent the continuous action of biogenic amines, the body must inactivate them. This occurs via two main pathways:
1. Methylation Typical for histamine, epinephrine, and norepinephrine. The reaction is catalyzed by methyltransferases, with SAM serving as the methyl group donor. For example, epinephrine is converted to metanephrine by replacing the hydrogen of the ring hydroxyl group with a methyl radical (-O-$CH_3$).
2. Oxidative Deamination Typical for dopamine, serotonin, GABA, and norepinephrine. This is mediated by monoamine oxidases (MAO) with an FAD cofactor. The biogenic amine loses ammonia ($NH_3$), converts into an aldehyde, and is subsequently oxidized to an acid. These acids are ultimately excreted by the kidneys.
Note: GABA can also be inactivated via an alternative pathway—transamination to succinate, which is then oxidized in the tricarboxylic acid (TCA) cycle.